Pfizer Animal Health

Get more information about a specific species.


MEDROL®
(methylprednisolone)
Tablets

More Anti-Inflammatory Action. Better Side-Effect Profile.

MEDROL® (methylprednisolone) improves anti-inflammatory action by 25%, with even less tendency to induce sodium and water retention. With its enhanced potency, lower doses of MEDROL achieve results similar to prednisone and prednisolone, but reduce the risk of side effects. MEDROL offers more anti-inflammatory action than any other medication in its class and with an unsurpassed side-effect profile.

Indications

  • Dermal conditions, such as non-specific eczema, summer dermatitis and burns

  • Allergic manifestations, such as acute urticaria, allergic dermatitis, drug and serum reactions, bronchial asthma, and pollen sensitivities

  • Ocular conditions, such as iritis, iridocyclitis, secondary glaucoma, uveitis and chorioretinitis

  • Otic conditions, such as otitis externa

  • Musculoskeletal conditions, such as myositis, rheumatoid arthritis, osteoarthritis, and bursitis

  • Various chronic or recurrent diseases of unknown etiology, such as ulcerative colitis and nephrosis
Key Features
  • Fast Action: Achieves peak serum levels in 1 hour to 2 hours, to relieve itching quickly.

  • Safe and Effective: Offers the same itch relief as prednisolone, but with less potential for side effects.

  • Convenient: Small, easy-to-swallow tablets are cross-scored for easy dose adjustment. Each 4-mg tablet contains 4 mg methylprednisolone.

  • Cost Effective: MEDROL tablets still cost only pennies a day.
Packaging

Bottles of 500

Dosage/Administration

Average daily total oral dosage for dogs is:

  • 5 to 15 lbs body weight – use 2 mg
  • 16 to 40 lbs body weight – use 2 to 4 mg
  • 41 to 80 lbs body weight – use 4 to 8 mg
    The total daily dose should be given in divided doses, 6 to 10 hours apart.

    Download product detailer (PDF).

    Precautions

    As with other cortiocosteroids, this product is contraindicated in animals with tuberculosis, hyperadrenocorticism and peptic ulcers. Use may induce parturition when administered during the last trimester of pregnancy, may be associated with other birth-related complications and may result in congenital birth defects.

    Suppression of inflammation may mask the signs of infection. Patients should be watched for evidence of concurrent infection.

    Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Not for use in humans.

    Product Information

    Back to top

    entire article (printer friendly)

    • Locate a Product

    Use the menus below to find product information.

     View all PfizerAH Dogs products

    Locate a Product

    There are no scheduled
    events listed at this time.

    Search
     
    Advanced Search




    Copyright © 2010 Pfizer Inc. All rights reserved.


    The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

    The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.